Searched for
BIOCON CHIEF
Syngene International MD & CEO Peter Bains resignsBains has resigned from the position of MD & CEO with effect from the close of business hours on June 30, Syngene International said in a r...- Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
- Intellectual curiosity & infectious optimism: Industry cheers Kunal Shah's new role as WhatsApp HeadIndia Inc. is celebrating Kunal Shah's appointment as WhatsApp head, hailing it as a milestone for Indian startup leadership. Industry lead...
- Bajaj auto foundation commits ₹400 crore for women in engineering, unveils ₹1,500-crore skilling planIn a bold step towards gender equality in engineering, Bajaj Auto Foundation is initiating a robust scholarship program for women in core e...
- West Bengal's electronics factory push; Fed jitters hit TCSWest Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.
- Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 crore from Singularity AMC, Rainmatter, othersThe Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...
- Industry expects policy continuity, faster execution under Shivakumar in KarnatakaExecutives from the technology, semiconductor and digital economy ecosystem said Karnataka’s long-standing strengths in talent, research an...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Biocon Q4 Results: Net profit down 57% at Rs 198.6 croreBiocon Ltd reported a 56.8% drop in Q4 net profit to Rs 198.6 crore, impacted by an Rs 80.4 crore exceptional item. Despite this, consolida...
- Kiran Mazumdar-Shaw picks niece Claire as successor at BioconBiocon's founder Kiran Mazumdar-Shaw has made a groundbreaking announcement, pledging her niece Claire Mazumdar as her heir apparent. The t...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
- With sights on huge gains, Biocon to scale up AI focusBiopharma major Biocon is significantly scaling up its adoption of artificial intelligence across its operations, from R&D to manufacturing...
- Biocon names insider Shreehas Tambe as MD & CEO for 5 years as Siddharth Mittal steps downBiocon announced a leadership change. Siddharth Mittal will step down as Managing Director and Chief Executive Officer on March 31. He will...
- Biocon chief Kiran Mazumdar-Shaw questions source of reports claiming that she had offered to repair roads in BengaluruKiran Mazumdar-Shaw, the entrepreneurial force behind Biocon, has playfully dismissed claims that she proposed funding for Bengaluru's road...
- Biocon chief Kiran Mazumdar-Shaw meets Karnataka Deputy CM DK Shivakumar amidst feudBiocon chief Kiran Mazumdar-Shaw met Karnataka Deputy Chief Minister DK Shivakumar to discuss Bengaluru's growth and innovation. This meeti...
- Powered by innovative drugs, pharma industry can be worth $200 billion by 2030, says Biocon chief Kiran Mazumdar-ShawResearch-based incentives can boost the domestic pharmaceutical sector, making it worth USD 200 billion by 2030, according to Biocon Execut...
- Biocon elevates M B Chinappa as CFO of biosimilar subsidiaryM B Chinappa, who is going to play an important role in Biocon Biologics’ journey towards becoming a global leader in biologics, has been t...
- Biocon elevates Siddharth Mittal as CEO and joint MDMittal takes over from Arun Chandavarkar who retired as chief executive and joint MD of the company on November 30.
- Biocon chief Kiran Mazumdar-Shaw: Dent vehicle bonnets to discipline violators“If our traffic police can enforce lane discipline like they do in Chennai & Mumbai half of Bengaluru’s traffic gridlock will be eliminated...
Load More
